SOPHARMA AD: Current report 22 buy back 20022014

opublikowano: 2014-02-20 13:42

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_22_buy_back_20022014.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 22 / 2014
Date of issue: 2014-02-20
Short name of the issuer
SOPHARMA AD
Subject
Current report 22 buy back 20022014
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
SOPHARMA AD (the “Company") hereby informs that from 13 February 2014 up to and including 19 February 2014 the Company bought 1 500 own shares representing 0.0011% of the share capital of the Company, to the total value of 6 420.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.28 BGN.

The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 029 373, representing 3.81% of the share capital of the Company.
Annexes
File Description
Current report 22 buy back 20022014.docCurrent report 22 buy back 20022014.doc Current report 22 buy back 20022014

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2014-02-20 Ognian Donev Executive director